48 results
10-Q
2022 Q2
EX-10.2
FHTX
Foghorn Therapeutics Inc
Quarterly report
9 Aug 22
12:00am
10-Q
2022 Q2
EX-10.1
FHTX
Foghorn Therapeutics Inc
Quarterly report
9 Aug 22
12:00am
8-K
EX-10.1
qz4h5toy
13 Dec 21
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn’s Proprietary Gene Traffic
6:04am
8-K
EX-10.1
yhwt3 j5fl
15 Jun 21
Entry into a Material Definitive Agreement
7:30am
10-K
EX-10.18
mrywbi qmu59d
18 Mar 21
Annual report
4:02pm
8-K
EX-10.1
n2r7ga7ad8y72
25 Nov 20
Entry into a Material Definitive Agreement
4:00pm
S-1/A
EX-10.16
j1acss8wagm
19 Oct 20
IPO registration (amended)
6:06am
S-1/A
EX-10.10
1hxq cosuhk3j1yr
19 Oct 20
IPO registration (amended)
6:06am
S-1/A
EX-10.12
2xcrdzvwzrszv
19 Oct 20
IPO registration (amended)
6:06am